Vericel

MACI

Manufacturer:

Vericel

Maci HCPCS:

J7330

HCPCS Code Descriptor:

Autologous cultured chondrocytes, implant

Category:

J Code

Maci NDCs:

69866-1030-05, 69866-1030-08

Primary Type:

Orthopedic

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Implantation

Maci CPT Codes:

Potential CPT administration codes for Maci can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

69866-1030-08, 69866-1030-05

About Maci:

MACI is an Orthopedic drug manufactured by Vericel and administered via the Implantation route of administration. The J Code: J7330 is aligned to the drug MACI.

MACI is an implant used to help repair damaged cartilage in certain joints of the body. This implant works by turning autologous cells into a film then placing this film on the damaged tissue. MACI is produced by Vericil corporation. MACI has been aligned to the HCPCS code J7330 since July 1st, 2002, and is still aligned to this HCPCS code. Patient assistance programs for this implant can be found through the Johnson and Johnson Patient Assistance Foundation.

ACCESS PRICING AND MORE BY REGISTERING

J7330 Added Date:

January 1, 2001

J7330 Effective Date:

July 1, 2002

J7330 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Maci billing and coding information.
Maci patient assistance information can be found through The Johnson and Johnson Patient Assistance Foundation at the URL: https://www.jjpaf.org/
MACI prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for MACI. Please check back in a few weeks.